Author:
Chunduri S,Dobogai L C,Peace D,Saunthararajah Y,Chen H Y,Mahmud N,Quigley J,Hoffman R,Jessop E,Beri R,Rondelli D
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Reference27 articles.
1. Zinzani PL, Lauria F, Rondelli D, Benfenati D, Raspadori D, Bocchia M et al. Fludarabine: an active agent in the treatment of previously-treated and untreated low-grade non-Hodgkin's lymphoma. Ann Oncol 1993; 4: 575–578.
2. Lenz G, Hiddemann W, Dreyling M . The role of fludarabine in the treatment of follicular and mantle cell lymphoma. Cancer 2004; 101: 883–893.
3. Czuczman MS, Koryzna A, Mohr A, Stewart C, Donohue K, Blumenson L et al. Rituximab in combination with fludarabine chemotherapy in low-grade or follicular lymphoma. J Clin Oncol 2005; 23: 694–704.
4. Hallek M, Schmitt B, Wilhelm M, Busch R, Krober A, Fostitsch HP et al. Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study Group. Br J Haematol 2001; 114: 342–348.
5. Terenzi A, Aristei C, Aversa F, Perruccio K, Chionne F, Raymondi C et al. Efficacy of fludarabine as an immunosuppressor for bone marrow transplantation conditioning: preliminary results. Transplant Proc 1996; 28: 3101.
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献